鼻内物质使用者的慢性鼻窦炎结构化组织病理学发现
本研究回顾了2021年1月至2024年10月接受内镜鼻窦手术的成人难治性慢性鼻窦炎(CRS)患者,比较有记录鼻内物质使用者与无使用者。共识别21例使用者,其中性粒细胞浸润、基底膜增厚、上皮下水肿、鳞状化生和纤维化比例均显著高于非使用者。结论提示此类患者应重视物质使用评估、戒断咨询和术后监测。
要点
- 鼻内物质使用CRS患者中性粒细胞浸润比例显著高于非使用者。
- 使用者基底膜增厚、上皮下水肿、鳞状化生和纤维化比例均更高。
- 建议对此类患者进行物质使用评估、戒断咨询及术后密切监测。
核心结论
- 有记录鼻内物质使用的CRS患者表现出更明显的中性粒细胞炎症及上皮损伤和重塑的组织学特征。
研究设计与样本
- 回顾性队列研究,纳入2021年1月至2024年10月接受内镜鼻窦手术的成人难治性CRS患者,比较有记录鼻内物质使用者(21例)与无使用者。
主要发现
- 使用者中报告物质包括大麻10例(47.6%)、可卡因6例(28.6%)、海洛因2例(9.5%)、涉及超过3种物质的多物质使用3例(14.3%)。
- 使用者男性比例高于非使用者(76.2% vs. 46.4%,p=0.008),CRS亚型分布差异有统计学意义(p<0.001)。
- 使用者中性粒细胞浸润率高于非使用者(33.4% vs. 10.7%,p=0.001)。
- 使用者基底膜增厚率(100% vs. 31.0%,p<0.001)、上皮下水肿率(90.4% vs. 25.8%,p<0.001)、鳞状化生率(42.9% vs. 20.8%,p=0.016)和纤维化率(38.0% vs. 20.8%,p=0.013)均高于非使用者。
- 年龄和种族分布无显著差异。
临床怎么用
- 对CRS患者应仔细评估鼻内物质使用情况,并提供戒断咨询。
- 对此类患者术后应加强监测和随访。
局限性
- 样本量较小(使用者21例),需更大规模研究验证组织病理学差异对治疗反应和手术结局的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To characterize structured sinonasal histopathology findings among patients with chronic rhinosinusitis (CRS) and documented intranasal substance use undergoing endoscopic sinus surgery. METHODS: Adult patients with medically recalcitrant CRS who underwent endoscopic sinus surgery between January 2021 and October 2024 were reviewed. Patients with documented intranasal substance use were compared with CRS patients without documented substance use. Demographic, clinical, and structured histopathology variables were analyzed using chi-square, Fisher exact, and Student's t-tests, as appropriate. RESULTS: Twenty-one CRS patients with documented intranasal substance use were identified. Reported substances included cannabis in 10 patients (47.6%), cocaine in 6 patients (28.6%), heroin in 2 patients (9.5%), and polysubstance use involving more than 3 substances in 3 patients (14.3%). Compared with non-users, substance users were more frequently male (76.2% vs. 46.4%, p = 0.008) and differed by CRS subtype distribution (p < 0.001). No significant differences were observed by age or race. Substance users had higher rates of neutrophil infiltrate (33.4% vs. 10.7%, p = 0.001), basement membrane thickening (100% vs. 31.0%, p < 0.001), subepithelial edema (90.4% vs. 25.8%, p < 0.001), squamous metaplasia (42.9% vs. 20.8%, p = 0.016), and fibrosis (38.0% vs. 20.8%, p = 0.013). CONCLUSION: CRS patients with documented intranasal substance use demonstrated greater neutrophilic inflammation and histologic features of epithelial injury and remodeling compared with non-users. These findings support careful substance-use assessment, cessation counseling, and postoperative surveillance in this population. Larger studies are needed to determine whether these histopathologic differences influence treatment response and surgical outcomes.
引用
- Haji RA, Cyberski TF, Primer G, et al. Structured Histopathologic Findings in Chronic Rhinosinusitis Patients With Intranasal Substance Use. Laryngoscope. 2026. PMID: 42764628. doi:10.1002/lary.70918
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。